Abbott Drops Price of HIV/AIDS Drug Kaletra in Brazil

The Brazilian Ministry of Health signed an agreement last week (4 July) with the pharmaceutical company Abbott Laboratories to reduce the price of its HIV/AIDS drug Kaletra by 29.5 per cent.

Leave a Reply

Your email address will not be published. Required fields are marked *